AROMATIC DIAMINE, AN INTERMEDIATE THEREFOR, A METHOD FOR PRODUCING THE AROMATIC DIAMINE, AND A METHOD FOR PRODUCING THE INTERMEDIATE THEREFOR
申请人:SEIKA CORPORATION
公开号:US20180079732A1
公开(公告)日:2018-03-22
A novel asymmetric diamine, diamino-2-(benzothiazole-2-yl)diphenyl ether, derivatives therefor, and an intermediate for the compound such as aminonitro-2-(benzothiazole-2-yl)diphenyl ether, dinitro-2-(benzothiazole-2-yl)diphenyl ether, and derivatives from these. Additionally, another novel asymmetric diamine, diamino-2-(benzoxazole-2-yl)diphenyl ether, derivatives therefor, and intermediate for the compound such as aminonitro-2-(benzoxazole-2-yl)diphenyl ether, dinitro-2-(benzoxazole-2-yl)diphenyl ether, and derivatives from these, and methods for preparing them.
NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METATROPIC GLUTAMATE RECEPTORS
申请人:Bessis Anne-Sophie
公开号:US20090124625A1
公开(公告)日:2009-05-14
The present invention relates to novel compounds of formula (I) wherein W, n, X and W′ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors—subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
申请人:Bessis Anne-Sophie
公开号:US20120277237A1
公开(公告)日:2012-11-01
The present invention relates to novel compounds of formula I wherein W, n, X and W′ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors—subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Alkynyl derivatives as modulators of metabotropic glutamate receptors
申请人:Addex Pharma SA
公开号:EP2426115A2
公开(公告)日:2012-03-07
The present invention relates to novel compounds of formula I wherein W, n, X and W' are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 ("mGluR5") which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
本发明涉及式 I 的新型化合物,其中 W、n、X 和 W' 在描述中定义;本发明化合物是代谢谷氨酸受体-亚型 5("mGluR5")的调节剂,可用于治疗中枢神经系统疾病以及受 mGluR5 受体调节的其他疾病。
Mukherji, S.K.; Jain, Mukesh; Gupta, Archana, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1994, vol. 33, # 10, p. 990 - 991